TAF12 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.496400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.806400E-01
Normal-vs-Stage2
8.573600E-01
Normal-vs-Stage3
2.945800E-01
Normal-vs-Stage4
2.218000E-01
Stage1-vs-Stage2
4.726400E-01
Stage1-vs-Stage3
6.864200E-01
Stage1-vs-Stage4
5.864400E-02
Stage2-vs-Stage3
3.202800E-01
Stage2-vs-Stage4
1.691210E-01
Stage3-vs-Stage4
7.208200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.578000E-01
Normal-vs-AfricanAmerican
9.017600E-01
Normal-vs-Asian
4.537400E-01
Caucasian-vs-AfricanAmerican
5.472000E-01
Caucasian-vs-Asian
4.493800E-01
AfricanAmerican-vs-Asian
3.062600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.042000E-01
Normal-vs-Female
8.129200E-01
Male-vs-Female
6.231400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.697400E-01
Normal-vs-Age(41-60Yrs)
7.507000E-01
Normal-vs-Age(61-80Yrs)
5.719400E-01
Normal-vs-Age(81-100Yrs)
3.471000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.831640E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.938800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.872800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.218200E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.394300E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.755600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.087200E-01
Normal-vs-Daily Drinker
8.326000E-01
Normal-vs-Weekly Drinker
8.683600E-01
Normal-vs-Occasional Drinker
8.375600E-01
Normal-vs-Social Drinker
7.224800E-01
Non Drinker-vs-Daily Drinker
1.831000E-01
Non Drinker-vs-Weekly Drinker
2.469200E-01
Non Drinker-vs-Occasional Drinker
1.097370E-01
Non Drinker-vs-Social Drinker
1.805560E-01
Daily Drinker-vs-Weekly Drinker
9.752000E-01
Daily Drinker-vs-Occasional Drinker
9.029200E-01
Daily Drinker-vs-Social Drinker
9.534800E-01
Weekly Drinker-vs-Occasional Drinker
9.443200E-01
Weekly Drinker-vs-Social Drinker
9.343800E-01
Occasional Drinker-vs-Social Drinker
8.342600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.463800E-01
Normal-vs-Grade 2
8.978800E-01
Normal-vs-Grade 3
8.719200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.58208999999632E-05
Grade 1-vs-Grade 3
2.396200E-03
Grade 1-vs-Grade 4
7.463800E-01
Grade 2-vs-Grade 3
4.034800E-01
Grade 2-vs-Grade 4
8.978800E-01
Grade 3-vs-Grade 4
8.719200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.512800E-01
Normal-vs-NonDiabetic
7.255000E-01
Diabetic-vs-NonDiabetic
4.507600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.149800E-01
Normal-vs-NoPancreatitis
7.144400E-01
Pancreatitis-vs-NoPancreatitis
5.993800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.326200E-01
Normal-vs-N1
8.852800E-01
N0-vs-N1
1.252210E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.274800E-01
Normal-vs-TP53-NonMutant
7.015800E-03
TP53-Mutant-vs-TP53-NonMutant
1.971920E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
